PET oncology research in the UK, USA, and Europe
Published
22 October 2012
| Article by Nuclear Medicine Communications 2012
| Tags:
oncology,
cancer,
pet,
clinical-trials,
fluorodeoxyglucose,
radiotracers
PET oncology research in the UK, USA, and Europe
During the last three decades, PET imaging has developed into a valuable clinical procedure. Widespread availability and increased affordability of F-fluorodeoxyglucose (FDG) have played an important part in this process. FDG-PET is now an important tool in oncology patient management and drug development....
To read the full article, please register for GetInsideHealth below.
Register for GetInsideHealth
GetInsideHealth is free and registration is easy. You'll have exclusive access to a huge range of industry-specific features and news reports from some of the most respected commentators on health and well-being, with an emphasis on the latest developments and innovations in cardiology, oncology, radiology, and OBGYN.
Please fill in the form below to register.
Already Registered?
Please login using
form at top of page
Fields with an asterisk (*) are mandatory
About you
Login information
Newsletter
Additional information